Clinical Validation of the AliveCor Kardia 12L and 6L Devices

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.

Also called NCT05053243

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 221 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05053243
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05053243. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-27 (actual); primary completion 2022-02-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Validation of the AliveCor Kardia 12L and 6L Devices
Condition
Arrhythmia
Intervention (Device)
Kardia 12L
Lead sponsor
University of Oklahoma (class: other)

Record details

Record id
cardio:ct-nct05053243
Content hash
3a1ffa39ae05f54e34c3d0310a81902feef7ffc4cc4cff1492e3809a3f1957f0